⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AMPH News
Amphastar Pharmaceuticals, Inc.
Base10 Partners Hits $2.6B AUM, Closes $850M to Back the Next Wave of Real Economy AI
prnewswire.com
NU
AMPH
OPRA
Amphastar Pharmaceuticals, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses
globenewswire.com
AMPH
Amphista Therapeutics announces FDA clearance of IND application for AMX-883, its lead Targeted Glue™ degrader for acute myeloid leukaemia
globenewswire.com
AMPH
Amphastar Pharmaceuticals to Present at the 2026 Jefferies Healthcare Conference
accessnewswire.com
AMPH
Form 8-K
sec.gov
AMPH
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026
accessnewswire.com
AMPH
Albuterol Sulfate Metered Dose Inhalers Market Analysis Report 2026: $7.61 Bn Opportunities, Trends, Competitive Landscape, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
AMPH
TEVA
Amphastar Pharmaceuticals to Present at the 2026 Bank of America Health Care Conference
accessnewswire.com
AMPH
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7, 2026
accessnewswire.com
AMPH
Amphista Therapeutics announces presentation of new preclinical data from its SMARCA2 and TEAD Targeted Glue™ degrader programs at AACR 2026, and publication of the first data on its TEAD program
globenewswire.com
AMPH